GeneDx Holdings (WGS) Non-Current Debt (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Non-Current Debt data on file, last reported at $96.7 million in Q1 2026.

• Non-Current Debt for Q1 2026 came in at $96.7 million, up 86.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.7 million (up 86.76% YoY), and the FY2025 annual result was $48.2 million, down 7.2% from the prior year.
• Non-Current Debt improved to $96.7 million in Q1 2026 per WGS's latest filing, from $48.2 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $96.7 million in Q1 2026 and troughed at $6.1 million in Q3 2023.
• A 5-year average of $36.4 million and a median of $51.6 million in 2025 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2022 and 2024: Non-Current Debt sank 43.18% in 2022, then soared 759.78% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $6.2 million in 2022, then surged by 743.01% to $52.7 million in 2023, then retreated by 1.47% to $51.9 million in 2024, then retreated by 7.2% to $48.2 million in 2025, then soared by 100.79% to $96.7 million in 2026.
• Business Quant data shows WGS's Non-Current Debt at $96.7 million in Q1 2026, $48.2 million in Q4 2025, and $51.6 million in Q3 2025.